191 related articles for article (PubMed ID: 10995786)
1. Role of the Cdc25A phosphatase in human breast cancer.
Cangi MG; Cukor B; Soung P; Signoretti S; Moreira G; Ranashinge M; Cady B; Pagano M; Loda M
J Clin Invest; 2000 Sep; 106(6):753-61. PubMed ID: 10995786
[TBL] [Abstract][Full Text] [Related]
2. Multifaceted regulation of cell cycle progression by estrogen: regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function.
Foster JS; Henley DC; Bukovsky A; Seth P; Wimalasena J
Mol Cell Biol; 2001 Feb; 21(3):794-810. PubMed ID: 11154267
[TBL] [Abstract][Full Text] [Related]
3. Reduction of Cdc25A contributes to cyclin E1-Cdk2 inhibition at senescence in human mammary epithelial cells.
Sandhu C; Donovan J; Bhattacharya N; Stampfer M; Worland P; Slingerland J
Oncogene; 2000 Nov; 19(47):5314-23. PubMed ID: 11103932
[TBL] [Abstract][Full Text] [Related]
4. A rate limiting function of cdc25A for S phase entry inversely correlates with tyrosine dephosphorylation of Cdk2.
Sexl V; Diehl JA; Sherr CJ; Ashmun R; Beach D; Roussel MF
Oncogene; 1999 Jan; 18(3):573-82. PubMed ID: 9989807
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of cyclin-dependent kinase 2 by the Chk1-Cdc25A pathway during the S-phase checkpoint activated by fludarabine: dysregulation by 7-hydroxystaurosporine.
Sampath D; Shi Z; Plunkett W
Mol Pharmacol; 2002 Sep; 62(3):680-8. PubMed ID: 12181445
[TBL] [Abstract][Full Text] [Related]
6. Regulation of Cdc25A half-life in interphase by cyclin-dependent kinase 2 activity.
Ducruet AP; Lazo JS
J Biol Chem; 2003 Aug; 278(34):31838-42. PubMed ID: 12801928
[TBL] [Abstract][Full Text] [Related]
7. Rapid destruction of human Cdc25A in response to DNA damage.
Mailand N; Falck J; Lukas C; Syljuâsen RG; Welcker M; Bartek J; Lukas J
Science; 2000 May; 288(5470):1425-9. PubMed ID: 10827953
[TBL] [Abstract][Full Text] [Related]
8. Activation of the phosphatase activity of human cdc25A by a cdk2-cyclin E dependent phosphorylation at the G1/S transition.
Hoffmann I; Draetta G; Karsenti E
EMBO J; 1994 Sep; 13(18):4302-10. PubMed ID: 7523110
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of growth arrest by c-myc antisense oligonucleotides in MCF-7 breast cancer cells: implications for the antiproliferative effects of antiestrogens.
Carroll JS; Swarbrick A; Musgrove EA; Sutherland RL
Cancer Res; 2002 Jun; 62(11):3126-31. PubMed ID: 12036924
[TBL] [Abstract][Full Text] [Related]
10. Ectopic expression of Cdc25A accelerates the G(1)/S transition and leads to premature activation of cyclin E- and cyclin A-dependent kinases.
Blomberg I; Hoffmann I
Mol Cell Biol; 1999 Sep; 19(9):6183-94. PubMed ID: 10454565
[TBL] [Abstract][Full Text] [Related]
11. TNFalpha-mediated cell death is independent of cdc25A.
Krupitza G; Grusch M; Braun K; Fuhrmann G; Steinbrugger R; Hulla W; Simonitsch I; Chott A; Hengstschläger M
Cell Death Differ; 1998 Sep; 5(9):758-64. PubMed ID: 10200535
[TBL] [Abstract][Full Text] [Related]
12. Serine-Threonine Kinase 38 regulates CDC25A stability and the DNA damage-induced G2/M checkpoint.
Fukasawa T; Enomoto A; Miyagawa K
Cell Signal; 2015 Aug; 27(8):1569-75. PubMed ID: 25936524
[TBL] [Abstract][Full Text] [Related]
13. Cdc25-dependent activation of cyclin A/cdk2 is blocked in G2 phase arrested cells independently of ATM/ATR.
Goldstone S; Pavey S; Forrest A; Sinnamon J; Gabrielli B
Oncogene; 2001 Feb; 20(8):921-32. PubMed ID: 11314027
[TBL] [Abstract][Full Text] [Related]
14. Cyclin D2 activates Cdk2 in preference to Cdk4 in human breast epithelial cells.
Sweeney KJ; Sarcevic B; Sutherland RL; Musgrove EA
Oncogene; 1997 Mar; 14(11):1329-40. PubMed ID: 9178893
[TBL] [Abstract][Full Text] [Related]
15. Specificity of natural and artificial substrates for human Cdc25A.
Rudolph J; Epstein DM; Parker L; Eckstein J
Anal Biochem; 2001 Feb; 289(1):43-51. PubMed ID: 11161293
[TBL] [Abstract][Full Text] [Related]
16. The effects of GM-CSF, steel factor and MIP-1alpha on the expression and activation of Cdc25A phosphatase in Mo7e cells.
Reid S; Broxmeyer HE
Cytokines Cell Mol Ther; 1999 Sep; 5(3):129-38. PubMed ID: 10641570
[TBL] [Abstract][Full Text] [Related]
17. Expression of cyclin-dependent kinases and CDC25a phosphatase is related with recurrences and survival in women with peri- and post-menopausal breast cancer.
Bonin S; Brunetti D; Benedetti E; Gorji N; Stanta G
Virchows Arch; 2006 May; 448(5):539-44. PubMed ID: 16440198
[TBL] [Abstract][Full Text] [Related]
18. Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK) 2 and CDK4 in human breast carcinoma cells.
Carlson BA; Dubay MM; Sausville EA; Brizuela L; Worland PJ
Cancer Res; 1996 Jul; 56(13):2973-8. PubMed ID: 8674031
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
Coppock DL; Buffolino P; Kopman C; Nathanson L
Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
[TBL] [Abstract][Full Text] [Related]
20. Constitutive overexpression of cyclin D1 but not cyclin E confers acute resistance to antiestrogens in T-47D breast cancer cells.
Hui R; Finney GL; Carroll JS; Lee CS; Musgrove EA; Sutherland RL
Cancer Res; 2002 Dec; 62(23):6916-23. PubMed ID: 12460907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
